IL10 and glioblastoma: In GBM, for example, glycolysis inhibition decreases lactate-driven histone lactylation, downregulates the expression of immunosuppressive cytokines (e.g., IL-10), and restores CD8+ T-cell cytotoxicity, ultimately increasing responsiveness to immunotherapy [51].